glimepiride has been researched along with Fatty Liver in 1 studies
glimepiride: structure given in first source
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, H | 1 |
| Nagai, Y | 1 |
| Ohta, A | 1 |
| Tenjin, A | 1 |
| Nakamura, Y | 1 |
| Tsukiyama, H | 1 |
| Sasaki, Y | 1 |
| Fukuda, H | 1 |
| Ohshige, T | 1 |
| Terashima, Y | 1 |
| Sada, Y | 1 |
| Kondo, A | 1 |
| Sasaoka, T | 1 |
| Tanaka, Y | 1 |
1 trial available for glimepiride and Fatty Liver
| Article | Year |
|---|---|
Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fatty | 2015 |